THE USE OF CARBON DIOXIDE (CO2) LASER IN THE TREATMENT OF VULVOVAGINAL ATROPHY SYMPTOMS IN PERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN
Journal of Innovative Healthcare Practices,
Год журнала:
2024,
Номер
5(1), С. 30 - 39
Опубликована: Март 21, 2024
This
study
explores
the
efficacy
of
pixelated
carbon
dioxide
(CO2)
laser
treatment
in
mitigating
vulvovaginal
atrophy
symptoms
among
perimenopausal
and
postmenopausal
women.
examines
effectiveness
CO2
reducing
vaginal
discomfort
for
women
experiencing
menopause.
With
a
cohort
127
participants
(mean
age
47
±
5
years),
researchers
administered
three
sessions
over
months.
The
primary
evaluation
metric
was
patient-reported
satisfaction
levels,
aiming
to
assess
treatment's
impact
on
alleviating
associated
with
atrophy,
such
as
dryness,
burning,
during
intercourse.
findings
revealed
that
98%
patients
experienced
significant
symptom
improvement
months
post-treatment.
Notably,
89%
reported
resolution
sexual
dysfunction
due
96%
indicated
an
end
burning
sensations.
is
extremely
high,
being
satisfied
results,
this
has
persisted
even
after
some
time
following
treatment.
Furthermore,
95%
encountered
no
procedure,
any
post-treatment
complaints
were
mild
temporary,
watery
discharge
most
common.
concludes
pixel
practical,
painless,
efficient
approach
addressing
symptoms,
yielding
high
patient
rates.
finds
using
practical
painless
way
help
discomfort,
are
results.
Язык: Английский
Topical high concentration oxygen with hyaluronic acid: A safe and effective treatment for vaginal atrophy and sexual function improvement
Post Reproductive Health,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 15, 2024
Background
Genitourinary
syndrome
of
menopause
(GSM)
is
a
condition
affecting
many
postmenopausal
women.
Among
the
available
treatments,
vaginal
natural
oxygenation
device
(VNOD)
new
promising
option.
Aim
To
evaluate
safety
and
effectiveness
high
concentration
(HC)
oxygen
(O
2
)
hyaluronic
acid
(HA)
in
women
with
atrophy
(VA).
Methods
Study
1:
Ten
subjects
received
HA
O
at
21%
(sham
group)
ten
95%
(treatment
group).
All
completed
five
sessions
VNOD.
Evaluations
questionnaires
were
baseline,
before
each
session
one-month
follow-up:
Visual
Analogue
Scale,
Vaginal
Health
Index
(VHI),
Maturation
Value
(VMV),
Menopause
Quality
Of
Life
(MeNQoL),
Female
sexual
function
index
(FSFI)
distress
scale
(FSDS).
2:
52
VA
same
protocol
study
1
HC
HA.
Results
Treatment
was
well-tolerated.
In
1,
treatment
group
we
recorded
significant
improvements
VHI
score
(
p-value
0.001),
VMV
0.005)
psychosocial,
physical
domains
MeNQoL
compared
to
sham
group.
2,
all
experienced
improvement
<0.001),
FSFI
total
0.007),
desire
0.004),
lubrication
0.006),
satisfaction
0.042),
pain
0.001)
domains,
FSDS
0.003)
domain
<0.001).
Conclusion
The
preliminary
results
this
suggest
that
VNOD
safe
effective
for
women,
improves
function.
Язык: Английский
Vaginal CO2 Fractional Laser in Women With Vaginal Atrophy: Medical Insights on Short- and Long-term Effects on Genitourinary Symptoms
Journal of lasers in medical sciences,
Год журнала:
2024,
Номер
15, С. e59 - e59
Опубликована: Ноя. 27, 2024
Introduction:
Genitourinary
syndrome
of
menopause
(GSM)
is
a
common
complication
secondary
to
estrogen
depletion
which
leads
tissue
changes
in
the
female
genitourinary
tract.
Here,
we
sought
investigate
short-
and
long-term
effects
CO2
laser
therapy
on
symptoms
GSM
postmenopausal
women.
Methods:
In
this
clinical
trial,
47
women
with
were
included.
Participants
underwent
vaginal
extra-vaginal
fractional
treatment
three
sessions,
intervals
one
month
between
each
session.
Symptom
severity,
including
itching,
dyspareunia,
discharge,
dryness,
was
assessed
at
session
using
modified
Vaginal
Health
Index
(VHI),
where
intensity
rated
Visual
Analog
Scale
(VAS)
from
1
10
(1
indicating
minimal
representing
maximum
severity).
Additionally,
International
Consultation
Incontinence
Questionnaire-Urinary
Short
Form
(ICIQ-UI
SF)
administered.
Patients
followed
for
years
after
final
Results:
The
scores
all
subscales,
urinary
incontinence,
improved
significantly
following
sessions
(p
values<0.001).
However,
except
incontinence
domain
(P=0.058),
none
maintained
last
intervention.
Conclusion:
appropriate
treating
related
GSM.
But
it
seems
that
needs
be
used
continuously
maintenance
effect
dryness.
exact
timing
should
identified
further
studies
since
beneficial
outcomes
intervention
seem
temporary.
Язык: Английский